Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?
Lipella Pharmaceuticals (LIPO) Investor Place·2024-07-29 12:20
Lipella Pharmaceuticals (NASDAQ:LIPO) stock is flying higher on Monday after the company presented investors with an update on its Phase 2a clinical trial evaluating LP-310. This is the company's drug candidate for the treatment of Oral Lichen Planus (OLP). That's a chronic inflammatory condition that affects more than 6 million Americans and lacks a Food and Drug Administration (FDA)-approved treatment. Lipella Pharmaceuticals CEO Dr. Jonathan Kaufman said the following about the news. "We are very pleased ...